XNCR
Xencor, Inc.
NASDAQ · USHealthcareBiotechnology
$18.90+8.19%
Price as of Jul 20, 2026
XNCR ownership
Xencor, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
6
Net (3m)
-$422.1K
Insider trades by month Buys Sells
May
Jun
Dec
Mar
Apr
Jun
Context3-month price +31.4%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 8, 2026 | GUSTAFSON KURT Adirector | Grant | 20,604 | $12.20 |
| Jul 8, 2026 | Deshaies Raymond Josephdirector | Grant | 10,302 | — |
| Jul 8, 2026 | SIMPSON TODD Edirector | Grant | 10,302 | — |
| Jul 8, 2026 | GUSTAFSON KURT Adirector | Grant | 10,302 | — |
| Jul 8, 2026 | GORMAN KEVIN CHARLESdirector | Grant | 10,302 | — |
| Jul 8, 2026 | Klencke Barbaradirector | Grant | 20,604 | $12.20 |
| Jul 8, 2026 | Feigal Ellendirector | Grant | 20,604 | $12.20 |
| Jul 8, 2026 | Montgomery Alan Brucedirector | Grant | 20,604 | $12.20 |
| Jul 8, 2026 | SIMPSON TODD Edirector | Grant | 20,604 | $12.20 |
| Jul 8, 2026 | RANIERI RICHARD Jdirector | Grant | 20,604 | $12.20 |
| Jul 8, 2026 | Feigal Ellendirector | Grant | 10,302 | — |
| Jul 8, 2026 | RANIERI RICHARD Jdirector | Grant | 10,302 | — |
| Jul 8, 2026 | Montgomery Alan Brucedirector | Grant | 10,302 | — |
| Jul 8, 2026 | GORMAN KEVIN CHARLESdirector | Grant | 20,604 | $12.20 |
| Jul 8, 2026 | Klencke Barbaradirector | Grant | 10,302 | — |
| Jul 8, 2026 | Deshaies Raymond Josephdirector | Grant | 20,604 | $12.20 |
| Jun 22, 2026 | Feigal Ellendirector | Sell | 6,843 | $13.06 |
| Jun 17, 2026 | Montgomery Alan Brucedirector | Sell | 5,064 | $12.31 |
| Jun 17, 2026 | GUSTAFSON KURT Adirector | Sell | 5,474 | $12.31 |
| Jun 17, 2026 | GORMAN KEVIN CHARLESdirector | Sell | 7,527 | $12.31 |
| Jun 17, 2026 | RANIERI RICHARD Jdirector | Sell | 5,474 | $12.31 |
| Apr 13, 2026 | Cornelissen Bart Janofficer: SR. VICE PRESIDENT & CFO | Sell | 3,499 | $12.29 |
| Mar 9, 2026 | Eckert Celiaofficer: SVP, GENERAL COUNSEL | Sell | 1,767 | $11.02 |
| Mar 9, 2026 | Desjarlais John Rofficer: SR. VICE PRESIDENT & CSO | Sell | 2,502 | $11.02 |
| Mar 9, 2026 | Eckert Celiaofficer: SVP, GENERAL COUNSEL | Sell | 3,244 | $11.25 |
| Mar 9, 2026 | Cornelissen Bart Janofficer: SR. VICE PRESIDENT & CFO | Sell | 2,517 | $11.25 |
| Mar 9, 2026 | Desjarlais John Rofficer: SR. VICE PRESIDENT & CSO | Sell | 4,118 | $11.25 |
| Mar 9, 2026 | Dahiyat Bassil Idirector, officer: PRESIDENT & CEO | Sell | 14,870 | $11.25 |
| Mar 9, 2026 | Dahiyat Bassil Idirector, officer: PRESIDENT & CEO | Sell | 6,606 | $11.02 |
| Mar 4, 2026 | Eckert Celiaofficer: SVP, GENERAL COUNSEL | Grant | 18,680 | — |
Source: XNCR SEC Form 4 filings, latest Jul 8, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their XNCR positions over the last 6 months (SEC Form 13F).
Increased
133
New positions
53
Reduced
151
Sold out
60
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 13.0M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 11.9M | Feb 12, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 10.3M | May 11, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 10.2M | Feb 11, 2026 |
| VANGUARD GROUP INC | Increased | 7.2M | Jan 29, 2026 |
| BVF INC/IL | Increased | 7.1M | Feb 17, 2026 |
| BVF INC/IL | Unchanged | 7.1M | May 15, 2026 |
| RTW INVESTMENTS, LP | Increased | 6.8M | Feb 17, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 6.8M | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | New Position | 4.9M | May 15, 2026 |
| STATE STREET CORP | Increased | 4.5M | Feb 13, 2026 |
| STATE STREET CORP | Reduced | 4.4M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 3.5M | May 8, 2026 |
| ECOR1 CAPITAL, LLC | Reduced | 3.3M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3.1M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.